Cargando…
Use of Glucagon in Patients With Type 1 Diabetes
IN BRIEF Glucagon is an invaluable tool for patients with type 1 diabetes who experience severe hypoglycemia, but little is known about the actual use of rescue glucagon in this patient population. This survey study found that patients with type 1 diabetes were not adequately prescribed glucagon or...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468823/ https://www.ncbi.nlm.nih.gov/pubmed/31057222 http://dx.doi.org/10.2337/cd18-0028 |
_version_ | 1783411522262794240 |
---|---|
author | Haymond, Morey W. Liu, Jingwen Bispham, Jeoffrey Hickey, Aileen McAuliffe-Fogarty, Alicia H. |
author_facet | Haymond, Morey W. Liu, Jingwen Bispham, Jeoffrey Hickey, Aileen McAuliffe-Fogarty, Alicia H. |
author_sort | Haymond, Morey W. |
collection | PubMed |
description | IN BRIEF Glucagon is an invaluable tool for patients with type 1 diabetes who experience severe hypoglycemia, but little is known about the actual use of rescue glucagon in this patient population. This survey study found that patients with type 1 diabetes were not adequately prescribed glucagon or educated about the use of glucagon, and patients reported various administration issues in using it. These results strongly suggest the need for standards of practice to increase the prescribing of glucagon and the provision of initial and ongoing education about its use and administration and the development of a glucagon rescue device or a glucagon product that would eliminate the complexity of its current formulation and packaging. |
format | Online Article Text |
id | pubmed-6468823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-64688232020-04-01 Use of Glucagon in Patients With Type 1 Diabetes Haymond, Morey W. Liu, Jingwen Bispham, Jeoffrey Hickey, Aileen McAuliffe-Fogarty, Alicia H. Clin Diabetes Feature Articles IN BRIEF Glucagon is an invaluable tool for patients with type 1 diabetes who experience severe hypoglycemia, but little is known about the actual use of rescue glucagon in this patient population. This survey study found that patients with type 1 diabetes were not adequately prescribed glucagon or educated about the use of glucagon, and patients reported various administration issues in using it. These results strongly suggest the need for standards of practice to increase the prescribing of glucagon and the provision of initial and ongoing education about its use and administration and the development of a glucagon rescue device or a glucagon product that would eliminate the complexity of its current formulation and packaging. American Diabetes Association 2019-04 /pmc/articles/PMC6468823/ /pubmed/31057222 http://dx.doi.org/10.2337/cd18-0028 Text en © 2018 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details. |
spellingShingle | Feature Articles Haymond, Morey W. Liu, Jingwen Bispham, Jeoffrey Hickey, Aileen McAuliffe-Fogarty, Alicia H. Use of Glucagon in Patients With Type 1 Diabetes |
title | Use of Glucagon in Patients With Type 1 Diabetes |
title_full | Use of Glucagon in Patients With Type 1 Diabetes |
title_fullStr | Use of Glucagon in Patients With Type 1 Diabetes |
title_full_unstemmed | Use of Glucagon in Patients With Type 1 Diabetes |
title_short | Use of Glucagon in Patients With Type 1 Diabetes |
title_sort | use of glucagon in patients with type 1 diabetes |
topic | Feature Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468823/ https://www.ncbi.nlm.nih.gov/pubmed/31057222 http://dx.doi.org/10.2337/cd18-0028 |
work_keys_str_mv | AT haymondmoreyw useofglucagoninpatientswithtype1diabetes AT liujingwen useofglucagoninpatientswithtype1diabetes AT bisphamjeoffrey useofglucagoninpatientswithtype1diabetes AT hickeyaileen useofglucagoninpatientswithtype1diabetes AT mcauliffefogartyaliciah useofglucagoninpatientswithtype1diabetes |